The risk of all-cause mortality is inversely related to serum 25(OH)d levels

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 8, 2012, Pages 2792-2798

  Saliba, Walid ^a,b   Barnett, Ofra ^a   Rennert, Hedy S ^a   Rennert, Gad ^a,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HAEMEK MEDICAL CENTER   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; SERUM ALBUMIN; VITAMIN D;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; COHORT ANALYSIS; COMORBIDITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HUMAN; ISRAEL; MALE; MORTALITY; PRIORITY JOURNAL; SMOKING; SOCIOECONOMICS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; RISK; VITAMIN D;

EID: 84864804892     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1747     Document Type: Article

References (40)

1. Holick MF 2007 Vitamin D deficiency. N Engl J Med 357:266-281
2. Saliba W, Rennert HS, Kershenbaum A, Rennert G 2012 Serum 25(OH)D concentrations in sunny Israel. Osteoporos Int 23:687-694
3. Pearce SH, Cheetham TD 2010 Diagnosis and management of vitamin D deficiency. BMJ 340:b5664
4. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society 2011 Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911-1930
5. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA 2008 Serum 25-hydroxyvitamin D status of the U.S. population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 88:1519-1527
6. Bikle D 2009 Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94:26-34
7. Maalouf NM 2008 The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hypertens 17:408-415
8. Autier P, Gandini S 2007 Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167:1730-1737 (Pubitemid 47403059)
9. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP 2002 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229-238 (Pubitemid 34787360)
10. Banerjee P, Chatterjee M 2003 Antiproliferative role of vitamin D and its analogs-a brief overview. Mol Cell Biochem 253:247-2454
11. Lee S, Clark SA, Gill RK, Christakos S 1994 1,25-Dihydroxyvitamin D3 and pancreatic β-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 134:1602-1610
12. Zasloff M 2006 Fighting infections with vitamin D. Nat Med 12:388-390
13. Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C 2011 Vitamin D and diabetes: its importance for β cell and immune function. Mol Cell Endocrinol 347:106-120
14. Mattila C, Knekt P,Männistö S, Rissanen H, Laaksonen MA, Montonen J, Reunanen A 2007 Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30:2569-2570 (Pubitemid 47547796)
15. Giovannucci E, Liu Y, Hollis BW, Rimm EB 2008 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168:1174-1180 (Pubitemid 351831400)
16. Leu M, Giovannucci E 2011 Vitamin D: epidemiology of cardiovascular risks and events. Best Pract Res Clin Endocrinol Metab 25:633-646
17. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H 2011 Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29:3775-3782
18. Engel P, Fagherazzi G, Boutten A, Dupré T, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F 2010 Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 19:2341-2350
19. Vaidya A, Forman JP 2010 Vitamin D and hypertension: current evidence and future directions. Hypertension 56:774-779
20. Zosky GR, Berry LJ, Elliot JG, James AL, Gorman S, Hart PH 2011 Vitamin D deficiency causes deficits in lung function and alters lung structure. Am J Respir Crit Care Med 183:1336-1343
21. Visser M, Deeg DJ, Puts MT, Seidell JC, Lips P 2006 Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 84:616-622; quiz 671-672
22. Melamed ML, Michos ED, Post W, Astor B 2008 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629-1637
23. Ginde AA, Scragg R, Schwartz RS, Camargo Jr CA 2009 Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57:1595-1603
24. Semba RD, Houston DK, Ferrucci L, Cappola AR, Sun K, Guralnik JM, Fried LP 2009 Lowserum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. Nutr Res 29:525-530
25. Fiscella K, Franks P 2010 Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med 8:11-18
26. Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R 2010 Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. Eur J Endocrinol 162:935-942
27. Virtanen JK, Nurmi T, Voutilainen S, Mursu J, Tuomainen TP 2011 Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr 50:305-312
28. Ford ES, Zhao G, Tsai J, Li C 2011 Vitamin D and all-cause mortality among adults in USA: findings from the National Health and Nutrition Examination Survey Linked Mortality Study. Int J Epidemiol 40:998-1005
29. Freedman DM, Looker AC, Chang SC, Graubard BI 2007 Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99:1594-1602
30. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, Lappé DL, Muhlestein JB; Intermountain Heart Collaborative (IHC) Study Group 2010 Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 106:963-968
31. Sambrook PN, Chen JS, March LM, Cameron ID, Cumming RG, Lord SR, Schwarz J, Seibel MJ 2004 Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 89:5477-5481 (Pubitemid 39518428)
32. Braun AB, Gibbons FK, Litonjua AA, Giovannucci E, Christopher KB 2012 Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med 40:63-72
33. National Academy of Science, Institute of Medicine 2010 Dietary references intake for calcium and vitamin D. http://www.nap.edu/catalog.php? record-id=13050. Accessed April 1, 2011
34. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA 2011 The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53-58
35. Saliba W, Barnett O, Rennert HS, Lavi I, Rennert G 2011 The relationship between serum 25(OH)D and parathyroid hormone levels. Am J Med 124:1165-1170
36. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W 2008 Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340-1349 (Pubitemid 351930842)
37. Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP 2010 Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 19:927-931
38. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G 2010 Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 171:903-908
39. Wang Y, Jacobs EJ, McCullough ML, Rodriguez C, Thun MJ, Calle EE, Flanders WD 2009 Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin D. Am J Epidemiol 170:88-94
40. Zittermann A, Börgermann J Vitamin D and mortality in heart failure (EVITA). www.clinicaltrials.gov/ct2/show/NCT01326650?term=vitamin=d=and=all= cause=mortality&rank=1. Accessed February 5, 2012